欢迎您!
东篱公司
退出
申报数据库
申报指南
立项数据库
成果数据库
期刊论文
会议论文
著 作
专 利
项目获奖数据库
位置:
成果数据库
>
期刊
> 期刊详情页
Meloxicam Executes Its Antitumor Effects against Hepatocellular Carcinoma in COX-2-Dependent and -In
ISSN号:1932-6203
期刊名称:PLos One
时间:2014.3.27
页码:-
相关项目:Clusterin通过线粒体凋亡通路调节肝细胞肝癌化疗耐受机理的研究
作者:
Jiang, Hongchi|Sun, Xueying|Li, Jie|Qiao, Haiquan|
同期刊论文项目
Clusterin通过线粒体凋亡通路调节肝细胞肝癌化疗耐受机理的研究
期刊论文 9
同项目期刊论文
Blocking autophagy enhances meloxicam lethality to hepatocellular carcinoma by promotion of endoplas
Meloxicam combined with sorafenib synergistically inhibits tumor growth of human hepatocellular carc
Downregulating sCLU enhances the sensitivity of hepatocellular carcinoma cells to gemcitabine by act
T7 peptide inhibits angiogenesis via downregulation of angiopoietin-2 and autophagy
Clusterin: Review of research progress and looking ahead to direction in hepatocellular carcinoma.
Integrin avb3 is required for cathepsin B-induced hepatocellular carcinoma progression.
Clusterin: Review of research progress and looking aheadto direction in hepatocellular carcinoma